Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Aquestive Therapeutics, Inc.

NASDAQ: AQSTHealthcare / Biotechnology / USA
6.89+0.4000+6.16%Vol 138 5161Y Perf -57.07%
Mar 18th, 2019 16:00
BID6.30 ASK7.04
Open6.65 Previous Close6.49
Pre-Market- After-Trading-
 - -%  - -%
Target Price
24.50 
Analyst Rating
— — 0.00
Potencial %
255.59 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)172 
Earnings Rating
Price Range Ratio 52wk %
8.54 
Earnings Date
-

Today's Price Range

6.327.04

 

52wk Range

5.6020.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
4.71%
3 Months
-0.14%
6 Months
-57.94%
1 Year
-57.07%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
AQST6.890.40006.16
AAPL188.021.90001.02
GOOG1 184.26-0.2000-0.02
MSFT117.571.66001.43
XOM81.080.93001.16
WFC51.731.07002.11
JNJ137.17-0.4300-0.31
FB160.47-5.5100-3.32
GE10.200.24002.41
JPM107.190.64000.60
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.00
Current Ratio
2.30
Long Term Debt to Total Capital
0.81
Total Debt to Equity
4.68
Interest Coverage
-7.00
Leverage Ratio -9.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
68.90
EBIT Margin
-79.60
EBITDA Margin
-74.80
Pre-tax Profit Margin
-
Profit Margin
-91.02

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume138 516
Shares Outstanding (in ths.)24 942
Trades Count747
Dollar Volume760 941
Avg. Volume121 014
Avg. Weekly Volume207 403
Avg. Monthly Volume148 931
Avg. Quarterly Volume128 207

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News